Synthetic modified messenger RNA for therapeutic applications

信使核糖核酸 生物 计算生物学 重编程 遗传增强 合成生物学 免疫原性 基因 免疫系统 遗传学
作者
Minsong Gao,Qingyi Zhang,Xin‐Hua Feng,Jianzhao Liu
出处
期刊:Acta Biomaterialia [Elsevier]
卷期号:131: 1-15 被引量:32
标识
DOI:10.1016/j.actbio.2021.06.020
摘要

Synthetic modified messenger RNA (mRNA) has manifested great potentials for therapeutic applications such as vaccines and gene therapies, with the recent mRNA vaccines for global pandemic COVID-19 (corona virus disease 2019) attracting the tremendous attention. The chemical modifications and delivery vehicles of synthetic mRNAs are the two key factors for their in vivo therapeutic applications. Chemical modifications like nucleoside methylation endow the synthetic mRNAs with high stability and reduced stimulation of innate immunity. The development of scalable production of synthetic mRNA and efficient mRNA formulation and delivery strategies in recent years have remarkably advanced the field. It is worth noticing that we had limited knowledge on the roles of mRNA modifications in the past. However, the last decade has witnessed not only new discoveries of several naturally occurring mRNA modifications but also substantial advances in understanding their roles on regulating gene expression. It is highly necessary to reconsider the therapeutic system made by synthetic modified mRNAs and delivery vectors. In this review, we will mainly discuss the roles of various chemical modifications on synthetic mRNAs, briefly summarize the progresses of mRNA delivery strategies, and highlight some latest mRNA therapeutics applications including infectious disease vaccines, cancer immunotherapy, mRNA-based genetic reprogramming and protein replacement, mRNA-based gene editing. The development of synthetic mRNA drug holds great promise but lies behind small molecule and protein drugs largely due to the challenging issues regarding its stability, immunogenicity and potency. In the last 15 years, these issues have beensubstantially addressed by synthesizing chemically modified mRNA and developing powerful delivery systems; the mRNA therapeutics has entered an exciting new era begun with the approved mRNA vaccines for the COVID-19 infection disease. Here, we provide recent progresses in understanding the biological roles of various RNA chemical modifications, in developing mRNA delivery systems, and in advancing the emerging mRNA-based therapeutic applications, with the purpose to inspire the community to spawn new ideas for curing diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1026完成签到,获得积分10
刚刚
3秒前
3秒前
高贵的鲜花完成签到,获得积分10
4秒前
4秒前
王菠萝完成签到,获得积分20
4秒前
Gauss应助向上走跑跳采纳,获得30
5秒前
王菠萝发布了新的文献求助10
8秒前
wwcjw发布了新的文献求助10
8秒前
农学小王完成签到 ,获得积分10
8秒前
CHOSENONE完成签到,获得积分10
8秒前
Ava应助HJC采纳,获得10
9秒前
9秒前
无情汉堡完成签到 ,获得积分10
10秒前
11秒前
小李完成签到 ,获得积分10
11秒前
dd完成签到,获得积分10
13秒前
传奇3应助CX采纳,获得10
14秒前
刘琪琪完成签到 ,获得积分10
15秒前
李健应助王菠萝采纳,获得10
16秒前
tutu完成签到,获得积分10
17秒前
左一完成签到,获得积分20
19秒前
翠甜翠甜大西瓜完成签到 ,获得积分10
24秒前
duoduo完成签到,获得积分10
25秒前
26秒前
张同学完成签到,获得积分10
26秒前
27秒前
xfy完成签到,获得积分10
27秒前
Fuchen完成签到,获得积分10
28秒前
xss完成签到,获得积分10
28秒前
矮小的寒天完成签到,获得积分10
30秒前
ptjam发布了新的文献求助10
31秒前
萧勒完成签到,获得积分10
32秒前
34秒前
dududu应助科研通管家采纳,获得20
34秒前
秋雪瑶应助科研通管家采纳,获得10
34秒前
深情安青应助科研通管家采纳,获得10
34秒前
pluto应助科研通管家采纳,获得10
34秒前
凤凰应助科研通管家采纳,获得30
34秒前
充电宝应助科研通管家采纳,获得10
34秒前
高分求助中
请在求助之前详细阅读求助说明!!!! 20000
Sphäroguß als Werkstoff für Behälter zur Beförderung, Zwischen- und Endlagerung radioaktiver Stoffe - Untersuchung zu alternativen Eignungsnachweisen: Zusammenfassender Abschlußbericht 1500
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
Yuwu Song, Biographical Dictionary of the People's Republic of China 700
[Lambert-Eaton syndrome without calcium channel autoantibodies] 520
The Three Stars Each: The Astrolabes and Related Texts 500
A radiographic standard of reference for the growing knee 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2469202
求助须知:如何正确求助?哪些是违规求助? 2136414
关于积分的说明 5443405
捐赠科研通 1860897
什么是DOI,文献DOI怎么找? 925519
版权声明 562701
科研通“疑难数据库(出版商)”最低求助积分说明 495140